Mustang Bio, Inc. (MBIO), a clinical-stage biopharmaceutical company, Thursday announced the pricing of a public offering of 2.65 ...

Mustang Bio (MBIO) announced the pricing of a public offering of an aggregate of 2,657,807 shares of its common stock, Series C-1 warrants to ...

BOULDER, Colo. - Gaia, Inc. (NASDAQ: NASDAQ:GAIA), known for its conscious media and community offerings, has announced the pricing of its public offering of 1.6 million shares of Class A common stock ...

Glucot (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing of a “best efforts” ...

BOULDER, Colo., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA) ("Gaia” or the "Company”), a conscious media and community company, announced today that it has priced its underwritten ...

Volcon, Inc. (Nasdaq:VLCN) (the “Company”), the first all-electric, off-road powersports company, today announced that it has commenced a public offering to offer and sell securities, including shares ...

BERWYN, Pa. - Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), a company engaged in developing drug delivery systems for pain management, announced the pricing of its public offering at $0.20 per share of ...

The Capital Market Authority (CMA) approved Saudi Economic and Development Securities Co.’s (SEDCO) request for the public ...

today announced the pricing of a best-efforts public offering of 762,500 common shares at a public offering price of $4.00 per share. Total gross proceeds from the offering, before deducting ...

In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering.